Avinger Receives Upgrade to Hold Rating by StockNews.com

Medical device company Avinger NASDAQ:AVGR received an upgrade from investment analysts at StockNews.com, changing its rating from a 'sell' to a 'hold'. This rating change was detailed in a recent report released on Friday, marking a significant shift in sentiment towards the company's stock.

Analyst Ratings and Price Target Changes

In addition to the upgrade by StockNews.com, Avinger has also seen a substantial increase in its price target from HC Wainwright. The investment firm has lifted its price target for Avinger from $1.60 to a robust $5.00, while simultaneously bestowing a 'buy' rating on the company's shares. This bullish stance by HC Wainwright suggests a strong confidence in Avinger's potential and future performance in the market.

Implications for Investors

The change in rating to a 'hold' suggests that analysts now believe Avinger's stock holds a balanced risk-reward profile, neither strongly undervalued nor overvalued at its current trading price. For investors, this indicates that Avinger now presents a more stable investment option, although it may not yet be seen as an aggressive growth opportunity. The new price target from HC Wainwright could signal potential upside, but investors are generally advised to conduct their own research in conjunction with analyst ratings.

Avinger, Upgrade, Analysts